Skip to main content
Clinical Trials/NL-OMON47609
NL-OMON47609
Completed
Phase 4

Short versus extended antibiotic treatment with a carbapenem for high-risk febrile neutropenia in hematology patients with Fever of Unknown Origin: a randomized multicenter open-label non-inferiority trial. - SHORT-trial

VUmc0 sites276 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
febrile neutropenia
Sponsor
VUmc
Enrollment
276
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
VUmc

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients with malignant hematological diseases being treated with cytotoxic chemotherapy or stem cell transplantation;;2\.High\-risk neutropenia;;3\.Fever;;4\.Age 18 years or older;;5\.Written informed consent.

Exclusion Criteria

  • 1\.Contraindications to use of imipenem\-cilastatin or meropenem such as allergy, previous severe side\-effects or previous microbiological cultures with carbapenem\-resistant microorganism(s).;2\.Corticosteroid use \*10 mg per day prednisolone or equivalent for more than 3 consecutive day during the previous 7 days.;3\.Clinically or microbiologically documented infection. ;4\.Symptoms of septic shock (systolic blood pressure \<90 mm Hg unresponsive to fluid resuscitation and/or oliguria (urine production \<500mL/day)).;5\.Previous enrollment in this study during the same episode of neutropenia. ;6\.Any critical illness for which Intensive Care Unit treatment is required.;7\.Legal incompetency

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Short versus extended antibiotic treatment for fever during low white blood cell counts in hematology patients with fever of unknown origin.Febrile neutropeniaMedDRA version: 19.1Level: PTClassification code 10063581Term: Stem cell transplantSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 19.1Level: LLTClassification code 10002969Term: Aplastic anemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 19.1Level: LLTClassification code 10003999Term: BacteremiaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: LLTClassification code 10007810Term: Catheter related infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: LLTClassification code 10028566Term: MyelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: LLTClassification code 10062957Term: Catheter bacteraemiaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: PTClassification code 10025310Term: LymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: LLTClassification code 10024329Term: LeukemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.1Level: PTClassification code 10056520Term: Catheter site infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 19.1Level: PTClassification code 10016288Term: Febrile neutropeniaSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2014-001546-25-NLVU University Medical Center240
Active, not recruiting
Phase 1
Short-course antibiotic regimen compared to conventional antibiotic treatment for gram-positive cocci infective endocarditis: randomized clinical trialinfective endocarditisTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2019-003358-10-ESCarmen Olmos Blanco298
Not yet recruiting
Not Applicable
Efficacy of Short-Course vs Long-Course Antibiotic Therapy for Community-Acquired Pneumonia:A Systematic Review and Meta-AnalysisCommunity-acquired pneumonia
JPRN-UMIN000049959Japan Respiratory Society
Completed
Phase 3
Duration of antibiotic therapy in patients with moderate or severe cholangitisHealth Condition 1: K830- Cholangitis
CTRI/2021/05/033535ot applicable120
Not yet recruiting
Phase 3
Comparing long and short duration antibiotics for abdominal infectionsHealth Condition 1: null- Complicated Intra-abdominal Infections
CTRI/2018/03/012682Jawaharlal Institute of PostGraduate Medical Education and Research